Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The ophthalmic devices market size is expected to grow from USD 50.61 billion in 2025 to USD 53.66 billion in 2026 and is forecast to reach USD 73.62 billion by 2031 at 6.53% CAGR over 2026-2031. This report is Segmented by Device Type (Diagnostic & Monitoring Devices, and More), Disease Indication (Cataract, Glaucoma, and More), End-User (Hospitals, Specialty Ophthalmic Clinics, Ambulatory Surgery Centers, and Other End-Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Ophthalmic Devices Market Trends and Insights

Expansion of Integrated Ophthalmology-Primary Care Clinics in Emerging Markets

Integrated eye-care hubs across India, China, and Southeast Asia embed tonometry, fundus photography, and visual-acuity tests into routine wellness visits, shortening referral cycles from six weeks to two days. India’s National Programme for Control of Blindness established 1,200 vision centers in 2024, each linked via tele-ophthalmology to tertiary hospitals, enabling the early detection of glaucoma and retinopathy while boosting equipment utilization for portable slit lamps and autorefractors. China’s Healthy China 2030 blueprint mandates annual eye exams for citizens over 60, stimulating the purchase of compact OCTs and handheld tonometers in township clinics that previously lacked ophthalmic capital assets. Private chains, such as Aravind Eye Care, offer turnkey clinic franchises that bundle diagnostics, EMR platforms, and workforce training, thereby accelerating ophthalmic device market penetration across Tier-2 and Tier-3 cities. Earlier detection pulls surgical volume forward, lifting cataract and MIGS procedures while lowering lifetime treatment costs, giving policymakers fiscal incentives to expand the model.

Growing Adoption of AI-Enabled Diagnostic Imaging Systems

Autonomous AI algorithms for diabetic retinopathy and AMD have received FDA and CE clearances, empowering primary-care teams to execute point-of-care retinal scans with over 90% sensitivity in under 60 seconds, comparable to the performance of retina specialists. EyeArt deployments reached over 900 U.S. sites by mid-2025, resulting in a 40% increase in retinopathy detection compared to legacy referral pathways, as patients receive same-visit results and immediate care plans. Payers reimburse USD 50-75 per AI scan, compared to USD 150 for specialist consultations, catalyzing rapid uptake in cost-conscious systems and reinforcing preventive care contracts. The technology also addresses workforce deficits, with the American Academy of Ophthalmology forecasting a shortage of 4,000 retina specialists by 2030, allowing specialists to focus on managing complex therapeutics while AI screens routine cases. Vendors now integrate AI modules directly into OCT and fundus platforms, converting hardware into software-upgradable assets and anchoring long-term service revenues.

High Capital Cost of Advanced Ophthalmic Equipment

Femtosecond lasers listed above USD 500,000 and swept-source OCT systems run USD 120,000-150,000, pricing out independent practices that perform fewer than 200 cataract surgeries per year, despite leasing programs that still demand USD 8,000-12,000 monthly. Public hospitals in India and Indonesia allocate under USD 50,000 annually for ophthalmic capital expenditure, delaying upgrades by half a decade and concentrating technology in urban centers. Zeiss launched a USD 75,000 OCT variant in 2025, trading scan density for affordability, but image-quality compromises slow uptake among clinicians sensitive to diagnostic accuracy. Capital hurdles thus curb the penetration of next-generation devices and temper the growth of the ophthalmic devices market in price-constrained geographies.

Other drivers and restraints analyzed in the detailed report include:

• Rising Prevalence of Vision Disorders in Aging Populations
• Surge in Employer-Funded Digital Eye-Health Wellness Programs
• Rising Cybersecurity Risks in Connected Diagnostic Devices

Geography Analysis

North America accounted for 39.94% of 2025 revenue, driven by Medicare funding for advanced imaging and MIGS devices. However, saturation limits growth to mid-single digits, as cataract penetration surpasses 90% of eligible patients. Autonomous AI screening approvals and 18 ophthalmic device clearances in 2024 sustain innovation, but the adoption of refurbished equipment and bundled contracts exerts pricing pressure on OEMs. Canada’s single-payer model constrains capital budgets for premium OCT and femtosecond lasers, shifting upgrade demand to private clinics serving self-pay patients willing to fund rapid access to advanced procedures.

The Asia Pacific is the fastest-growing region, with a 7.12% CAGR through 2031, driven by China’s Healthy China 2030 annual examination mandate and India’s rollout of 1,200 vision screening centers, which together add millions of diagnostic encounters each year. Japan and South Korea perform more than 1.5 million cataract surgeries annually, maintaining a high consumable pull-through for premium IOLs despite moderating device ASPs. Domestic manufacturers such as MOPTIM and Suowei captured 20% of China’s phacoemulsification systems market in 2025 by offering units at USD 30,000, a 50% discount to Western brands, and exporting to Southeast Asia, thereby expanding the regional ophthalmic devices market size. Rising medical tourism in Thailand and Singapore further scales the volume of refractive surgery, bundling LASIK with hospitality packages that attract regional patients and bolster sales of femtosecond lasers.

Europe generated 25% of global revenue in 2025; however, EU MDR compliance delayed 30% of planned product launches, temporarily constricting replenishment cycles and increasing refurbishment demand. NHS cataract wait times exceeding 18 months prompted private-sector chains, such as Optegra, to charge GBP 2,500 (USD 3,200) per eye for expedited surgery, stimulating demand for premium lenses and reinforcing the ophthalmic devices market in the UK. The Middle East & Africa and South America remain underpenetrated, with a 5% CAGR, as public systems focus on basic cataract interventions. However, mobile eye clinics and tele-diagnostics are expanding their reach into rural areas, setting the stage for the future growth of portable devices priced under USD 10,000.

List of Companies Covered in this Report:

• Alcon
• Bausch + Lomb
• Canon
• The Cooper Companies
• Glaukos
• HAAG-Streit
• Heidelberg Engineering, Inc.
• HOYA
• Johnson & Johnson Vision Care
• Danaher
• Lumibird Medical
• Lumenis
• Nidek
• Oculus
• STAAR Surgical
• Topcon
• Visionix
• Volk Optical
• Carl Zeiss
• Ziemer Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support